Company profile
Hemastatx
Targeting the mechanism behind bleeding
- Industry
- Biotechnology Research
- Employees
- 2
- Headquarters
- Allschwil, Basel-Country
- Founded
- 2025
- LinkedIn followers
- 462
- Office locations
- 2
Hemastatx company summary
Hemastatx is a company in the Biotechnology Research industry, headquartered in Allschwil, Basel-Country, founded in 2025. On LinkedIn the company has around 2 employees and 462 followers. The company lists 2 office locations.
What technology does Hemastatx use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Hemastatx
Hemastatx is committed to bringing scientific innovation to patients with severe and underserved bleeding disorders, aiming to become a leader in hematology. Founded in 2025 as a spin-off from KU Leuven, Hemastatx builds on over a decade of pioneering research in hemostasis at the Laboratory for Thrombosis Research, led by Prof. dr. Karen Vanhoorelbeke. Our first lead program, HMX-001, is a proprietary monoclonal antibody designed to present bleeding in patients with von Willebrand factor (VWF)-related disorders by targeting the underlying biological mechanism. The program is supported by a robust preclinical data package and broad patent protection. With headquarters in Switzerland and an R&D hub in Belgium, Hemastatx is strategically positioned within two of Europe’s leading biotech ecosystems.
Where is Hemastatx located?
Hemastatx lists 2 office locations.
Compare companies similar to Hemastatx
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Hemastatx hemastatx.com | Biotechnology Research | 2 | 2025 | Allschwil, Basel-Country |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Hemastatx
What does Hemastatx do?
Hemastatx is committed to bringing scientific innovation to patients with severe and underserved bleeding disorders, aiming to become a leader in hematology. Founded in 2025 as a spin-off from KU Leuven, Hemastatx builds on over a decade of pioneering research in hemostasis at the Laboratory for Thrombosis Research, led by Prof. dr. Karen Vanhoorelbeke. Our first lead program, HMX-001, is a proprietary monoclonal antibody designed to present bleeding in patients with von Willebrand factor (VWF)-related disorders by targeting the underlying biological mechanism. The program is supported by a robust preclinical data package and broad patent protection. With headquarters in Switzerland and an R&D hub in Belgium, Hemastatx is strategically positioned within two of Europe’s leading biotech ecosystems.
How many employees does Hemastatx have?
Hemastatx has around 2 employees on LinkedIn.
Where is Hemastatx headquartered?
Hemastatx is headquartered in Allschwil, Basel-Country.
Where does Hemastatx have offices?
Hemastatx lists 2 office locations, including Allschwil, Basel-Country, CH; Gosselies, 6041, BE.
When was Hemastatx founded?
Hemastatx was founded in 2025.
Build a lead list from companies like Hemastatx
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.